MERCK SHARP & DOHME CORP. v. APOTEX INC. et al > Summary
Court Case Number 3:17-cv-05399
Filing Date Jul 24, 2017
Termination Date Oct 11, 2017
Court New Jersey District Court
Status Judgment - Judgment on Consent
JudgesPeter G. Sheridan, Lois H. Goodman
Plaintiff
Defendant
Plaintiff Attorneys
9Merck Sharp & Dohme
Attorney Name: William C. Baton
Saul Ewing LLP
Merck Sharp & Dohme
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Merck Sharp & Dohme
Attorney Name: David Leigh Moses
Saul Ewing LLP
Merck Sharp & Dohme
Attorney Name: Bruce M. Wexler
Paul Hastings
Merck Sharp & Dohme
Attorney Name: Preston K. Ratliff II
Paul Hastings
Merck Sharp & Dohme
Attorney Name: Joseph O'Malley Jr.
Paul Hastings
Merck Sharp & Dohme
Attorney Name: William Krovatin
Merck Sharp & Dohme
Merck Sharp & Dohme
Attorney Name: Gerard M. Devlin Jr.
Merck Sharp & Dohme
Merck Sharp & Dohme
Attorney Name: Richard C. Billups
Merck Sharp & Dohme
Defendant Attorneys
6Apotex
Attorney Name: Michael Cross
Carella Byrne Cecchi Brody Agnello, P.C.
Apotex
Attorney Name: Melissa E. Flax
Carella Byrne Cecchi Brody Agnello, P.C.
Apotex
Attorney Name: Stephen R. Auten
Taft Stettinius & Hollister LLP
Apotex
Attorney Name: Richard T. Ruzich
Taft Stettinius & Hollister LLP
Attorney Name: Richard T. Ruzich
Attorney Name: Richard T. Ruzich
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 05691336 | Morpholine compounds are prodrugs useful as tachykinin receptor antagonists | Nov 25, 1997 |
